HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peixin Chen Selected Research

HLA-DRB6 antigen

1/2021DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peixin Chen Research Topics

Disease

17Neoplasms (Cancer)
11/2022 - 01/2020
11Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2021 - 02/2020
9Lung Neoplasms (Lung Cancer)
11/2022 - 02/2020
2Neoplasm Metastasis (Metastasis)
06/2021 - 04/2021
1Infections
11/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Airway Obstruction (Choking)
07/2021
1Pathologic Constriction (Stenosis)
07/2021
1Adenoid Cystic Carcinoma (Cylindroma)
07/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021
1Carcinoma (Carcinomatosis)
01/2021
1Lymphatic Metastasis
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Adenocarcinoma
01/2021
1Chronic Disease (Chronic Diseases)
10/2020
1Bites and Stings (Sting)
01/2020

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
02/2022 - 10/2020
4RNA (Ribonucleic Acid)IBA
01/2021 - 02/2020
3Biological ProductsIBA
06/2021 - 01/2020
3Immune Checkpoint InhibitorsIBA
02/2021 - 01/2020
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2020
2Proteins (Proteins, Gene)FDA Link
02/2022 - 04/2021
2AntigensIBA
01/2022 - 04/2021
2Programmed Cell Death 1 ReceptorIBA
09/2021 - 01/2021
2B7-H1 AntigenIBA
09/2021 - 01/2021
2MicroRNAs (MicroRNA)IBA
04/2021 - 02/2020
2Therapeutic UsesIBA
02/2021 - 02/2020
2Pharmaceutical PreparationsIBA
01/2021 - 06/2020
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
11/2022
1Racemases and Epimerases (Epimerases and Racemases)IBA
02/2022
1Dermatan SulfateIBA
02/2022
1Estrogen Receptor alphaIBA
02/2022
1Coloring Agents (Dyes)IBA
01/2022
1hepsinIBA
01/2022
1Monoamine Oxidase (MAO)IBA
07/2021
1CateninsIBA
04/2021
1Tumor Biomarkers (Tumor Markers)IBA
04/2021
1Cyclin-Dependent Kinase Inhibitor p16IBA
04/2021
1Keratin-19 (Keratin 19)IBA
04/2021
1Phosphopyruvate Hydratase (Enolase)IBA
04/2021
1Immunoglobulins (Immunoglobulin)IBA
02/2021
1PlatinumIBA
02/2021
1Monoclonal AntibodiesIBA
02/2021
1MucinsIBA
02/2021
1HLA-DRB6 antigenIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1SolutionsIBA
01/2021
1CytokinesIBA
01/2021
1Small Cytoplasmic RNAIBA
01/2021
1OX40 LigandIBA
01/2021
1CTLA-4 AntigenIBA
01/2020
1Cancer VaccinesIBA
01/2020
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2020
1AntibodiesIBA
01/2020
1InterferonsIBA
01/2020

Therapy/Procedure

10Immunotherapy
11/2022 - 01/2020
8Drug Therapy (Chemotherapy)
11/2022 - 02/2020
7Therapeutics
08/2021 - 01/2020